RP
ATRC icon

Riverwater Partners’s AtriCure ATRC Stock Holding History

Riverwater Partners’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.01M Buy
70,506
+10,184
+17% +$348K 0.67% 55
2025
Q4 		$2.39M Hold
60,322
– – 0.92% 29
2025
Q3 		$2.13M Buy
60,322
+26,657
+79% +$918K 0.88% 30
2025
Q2 		$1.1M Buy
+33,665
New +$1.09M 0.52% 65

Other funds holding ATRC

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverwater Partners's ATRC Position: Q1 2026 in Review

Riverwater Partners increased its AtriCure (ATRC) stake by 17% in Q1 2026, buying an estimated $348K and bringing the position to 70,506 shares worth $2.01M. The position accounts for 0.67% of the portfolio, ranked #55.

Riverwater Partners first reported a position in ATRC in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.39M in Q4 2025. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

  • Riverwater Partners held 70,506 shares of AtriCure worth $2.01M as of Q1 2026.
  • Riverwater Partners bought 10,184 AtriCure shares in Q1 2026, an estimated $348K.
  • AtriCure made up 0.67% of Riverwater Partners's portfolio in Q1 2026, its #55 holding.
  • Riverwater Partners first reported a position in AtriCure in Q2 2025 and has held it in 4 quarters since.
  • Riverwater Partners's AtriCure position peaked at $2.39M in Q4 2025.
  • 223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on Riverwater Partners's 13F filing for Q1 2026, filed 8 May 2026.